Taiwan FDA registration 874daea30394c07629df7164a6c4a3c4

Kang'er Xi rapid pregnancy test reagent series

TW: 康兒喜快速驗孕試劑系列

Taiwan·Risk Class 2·Kang'er Xi Biotech Co., Ltd.;; Dongyao Biotechnology Co., Ltd·Registered Jul 25, 2019 – Sep 28, 2025Expired

Registration details

Analysis ID: 874daea30394c07629df7164a6c4a3c4

Company information

Manufacturer: Kang'er Xi Biotech Co., Ltd.;; Dongyao Biotechnology Co., Ltd
Manufacturer Country: Taiwan, Province of China
Authorized Representative: KANG ERL SHII HEALTHCARE INTERNATIONAL CORP.

Product details

Intended Use: Urine is tested qualitatively for human chorionic gonadotropin (HCG).
Product Type (Level 1): A Clinical chemistry and clinical toxicology
Product Type (Level 2): A.1155 Human chorionic gonadotropin testing system
Import Information: Domestic;; Contract manufacturing

Dates and status

Registration Date: Jul 25, 2019
Expiry Date: Sep 28, 2025

About this record

Access comprehensive regulatory information for Kang'er Xi rapid pregnancy test reagent series in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 874daea30394c07629df7164a6c4a3c4 and manufactured by Kang'er Xi Biotech Co., Ltd.;; Dongyao Biotechnology Co., Ltd. The authorized representative in Taiwan is KANG ERL SHII HEALTHCARE INTERNATIONAL CORP..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.